Clinical trials

  • LY4256984 for Sporadic Amyotrophic Lateral Sclerosis | Amyotrophic lateral sclerosis
  • INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8)-LIKE STRAIN (CBER-RG8A) (CLADE 2.3.4.4B) for Influenza A (H5N8) | Influenza A (H5N1)
  • GAXILOSE for Lactose intolerance
  • INDOCYANINE GREEN for Symptomatic cholelithiasis
  • LAD191 for Hidradenitis suppurativa
  • LIDOCAINE HYDROCHLORIDE for Postanesthetic complications following open hepatectomy
  • BOTULINUM TOXIN TYPE A for Dystrophic scar | Post-sternotomy scarring
  • nitroglycerin for Chronic kidney disease | Coronary artery disease
  • AMIODARONE HYDROCHLORIDE for New-onset atrial fibrillation
  • TISLELIZUMAB for Locally advanced rectal cancer | Rectal cancer stage II | Rectal cancer stage III
  • ZONGERTINIB for Non-small cell lung cancer
  • N-[4-[2-[4-(3-CYANOPHENYL)PIPERAZIN-1-YL]ETHYL]CYCLOHEXYL]-3-METHOXYPROPANAMIDE for Obsessive compulsive disorder